Latest news
NUVB Stock Is Soaring Today — Why RBC Sees $3B Opportunity In Nuvation Bio's Brain Cancer Drug - StocktwitsStocktwits · Fri, 07 Aug 2026 15:55:52 GMTB. Riley Adjusts Price Target on Nuvation Bio to $15 From $12, Maintains Buy Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 14:19:35 GMTJ&J inks $1B deal for Firefly Bio and its degrader-antibody platform - FirstWord PHARMAFirstWord PHARMA · Thu, 06 Aug 2026 07:00:00 GMTAimar Peña (Mallorca B) - Bio, stats and news - 365Scores365Scores · Wed, 05 Aug 2026 21:36:57 GMTIs Bio-Rad Laboratories Inc (BIO) Overvalued After Q2 Earnings B - GuruFocusGuruFocus · Tue, 04 Aug 2026 23:50:32 GMTWhat Visa's $2.4B BioCatch deal means for your bank - American BankerAmerican Banker · Mon, 03 Aug 2026 20:47:00 GMTBridgeBio Pharma (BBIO) After Its $2.21b Stock Filing Is It A Buy Or Priced In - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 19:09:13 GMTVisa Acquires BioCatch For $2.4B – President Andrew Torre Says It Will Help Clients Stop Fraud Before It Reaches The Point Of Payment - StocktwitsStocktwits · Mon, 03 Aug 2026 11:58:44 GMT